Adverum Biotechnologies, Inc. ADVM
Set alert
At close · Dec 9
After hours · Dec 9, 4:00 PM ET
52-week range unavailable
- YTD
- -6.64%
- 1 year
- -26.23%
- Open
- 4.24
- Prev close
- 4.36
- Mkt cap
- 98.60M
- Vol
- 675.98K
- Avg vol
- 0
- EPS
- 0.00
- P/E
- 0.00
- Div yield
- 0.00%
More statistics
- Low
- 4.24
- High
- 4.36
- Forward P/E
- -0.89
- Beta
- 1.01
- Short ratio
- 5.53
- Inst. own
- 79.11%
- Dividend
- 0.00
- Ex-div date
- 50-d avg
- 6.82
- 200-d avg
- 8.42
- 1y target
- 29.71
Discussion (58)
Sign in to join the discussion
I legit don’t think I’ve ever seen a company get FDA approval and DROP in price. ??
Nolanmp26 ADVM 5 years ago #3Another sell off by weak minded people
Nolanmp26 ADVM 5 years ago #4Just needs a little buying pressure
Nolanmp26 ADVM 5 years ago #5Picked up some more. Let’s march to $4
Nolanmp26 ADVM 5 years ago #6Picked up another 500 shares. See where we are in 30 days
Nolanmp26 ADVM 5 years ago #7There will be no holding it down when they announce the shot was not the cause of the problem...
Nolanmp26 ADVM 5 years ago #8Goldman Sachs just put a $10 price on this even with the possibility of the adverse reaction being from the injection. Median target of $7. Um, I’ll take 100% gains for $3.60 Alex...
Nolanmp26 ADVM 5 years ago #9Down on no volume. That’s called a buying opportunity
Nolanmp26 ADVM 5 years ago #10I think Sonic is run by a liberal Democrat. “Let no tragedy go to waste”. As yet there is no proven connection between the 1 patient going blind and the injection. Yet Sonic is running off at the mouth, without evidence, trying to ram in the changes they want...
If the investigation shows no connection between the injection and the patients unfortunate condition, will Sonic come out and commend the board for their successful phase II trials?